Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Positive News Release
View:
Post by bealert on Dec 08, 2022 1:37pm

Positive News Release

The news has been released just in time to avoid tax loss selling, but some will sell anyway.

There are only two things that I believe about Sirona: They know just the right time to dangle the carrot again to retain investor interest after 13 odd years to perfect this art. The second thing I believe is they don't even know how inept they are at running a company and are too proud and stubborn to admit that someone else might do a better job. Yes, they know how to do financials and governance, etc. but are not able to negotiate any solid deals that will bring some REAL MONEY to the table.  Always a down the road thing and the share price tells the whole story.

I will give credit for the new test underway and all that good stuff, but I stick to my conviction that the shareholders have been given little respect over the years, the very people that provide their exorbitant paychecks.

Sirona, where is your 2023 budget for shareholders to examine?

BeAlert, and hope for the best.
Merry Christmas to all who read this, and a prosperous New Year.
Comment by lscfa on Dec 08, 2022 1:59pm
since there will be no clinical results for 3 months there is no risk in selling now for tax loss and re-acquiring in 31 days or later.  
Comment by forhandlaren on Dec 08, 2022 3:45pm
So the rational is that the company delayed the clinical trial until tax loss selling? I guess this is right up a conspiracy theorist alley... December is not over, still room for another NR. The diabetes pet deal for example.
Comment by MirrorWorldMan on Dec 08, 2022 2:34pm
A detailed action plan on how to harvest the results would be a good starting point as well. Together with preliminary leads with cosmetic firms that may anticipate the findings. Business planning is crucial now and I am hesitant to believe that Howies strategies and tactics are anymore than a "wait and see...our most molecules will sell themselves", approach. How can a part time busy ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities